Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID-19 Vaccine Effectiveness in Azerbaijan Health Workers
NCT05069454Unknown
- Sponsor
- Public Health and Reforms Center of the Ministry of Health
- Start
- May 2021
- Primary completion
- May 2022
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Open-label trial of coronavac in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Public Health and Reforms Center of the Ministry of Health. Primary endpoints: COVID-19 vaccine effectiveness at 12 months and Post-vaccination COVID-19 cases at 12 months. Status: unknown.
02
Drugs
coronavac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05069454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05069454.